chr2-79858113-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001282597.3(CTNNA2):​c.399G>A​(p.Ala133=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00386 in 1,613,988 control chromosomes in the GnomAD database, including 238 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 139 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 99 hom. )

Consequence

CTNNA2
NM_001282597.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.34
Variant links:
Genes affected
CTNNA2 (HGNC:2510): (catenin alpha 2) Enables actin filament binding activity. Involved in negative regulation of Arp2/3 complex-mediated actin nucleation; regulation of neuron migration; and regulation of neuron projection development. Located in cytoplasm. Implicated in complex cortical dysplasia with other brain malformations. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 2-79858113-G-A is Benign according to our data. Variant chr2-79858113-G-A is described in ClinVar as [Benign]. Clinvar id is 775737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.34 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0683 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CTNNA2NM_001282597.3 linkuse as main transcriptc.399G>A p.Ala133= synonymous_variant 4/19 ENST00000402739.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CTNNA2ENST00000402739.9 linkuse as main transcriptc.399G>A p.Ala133= synonymous_variant 4/191 NM_001282597.3 P26232-1

Frequencies

GnomAD3 genomes
AF:
0.0203
AC:
3094
AN:
152048
Hom.:
135
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0703
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00858
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0223
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.0144
GnomAD3 exomes
AF:
0.00541
AC:
1351
AN:
249530
Hom.:
53
AF XY:
0.00397
AC XY:
538
AN XY:
135374
show subpopulations
Gnomad AFR exome
AF:
0.0753
Gnomad AMR exome
AF:
0.00405
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000229
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000238
Gnomad OTH exome
AF:
0.00181
GnomAD4 exome
AF:
0.00214
AC:
3125
AN:
1461822
Hom.:
99
Cov.:
31
AF XY:
0.00177
AC XY:
1285
AN XY:
727192
show subpopulations
Gnomad4 AFR exome
AF:
0.0733
Gnomad4 AMR exome
AF:
0.00396
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000162
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000179
Gnomad4 OTH exome
AF:
0.00439
GnomAD4 genome
AF:
0.0204
AC:
3105
AN:
152166
Hom.:
139
Cov.:
32
AF XY:
0.0203
AC XY:
1507
AN XY:
74410
show subpopulations
Gnomad4 AFR
AF:
0.0704
Gnomad4 AMR
AF:
0.00850
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000235
Gnomad4 OTH
AF:
0.0142
Alfa
AF:
0.00843
Hom.:
22
Bravo
AF:
0.0231
Asia WGS
AF:
0.00404
AC:
15
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 31, 2019- -
Benign, criteria provided, single submitterclinical testingGeneDxMay 04, 2021- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
CTNNA2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesNov 20, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
5.8
DANN
Benign
0.83

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61754544; hg19: chr2-80085239; API